Callodine Capital Management, LP Viatris Inc Transaction History

Callodine Capital Management, LP

$428 Million
Q3 2024

A detailed history of Callodine Capital Management, LP transactions in Viatris Inc stock. As of the latest transaction made, Callodine Capital Management, LP holds 2,687,129 shares of VTRS stock, worth $33.3 Million. This represents 7.29% of its overall portfolio holdings.

Number of Shares

2,687,129

Previous 2,542,000 5.71%

Holding current value

$33.3 Million

Previous $27 Million 15.45%

% of portfolio

7.29%

Previous 6.85%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $1.5 Million - $1.76 Million	145,129 Added 5.71%	2,687,129 $31.2 Million
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $2.43 Million - $2.91 Million	242,000 Added 10.52%	2,542,000 $27 Million
Q1 2024 May 14, 2024	SELL	$11.27 - $13.53 $2.48 Million - $2.98 Million	-220,000 Reduced 8.73%	2,300,000 $27.5 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $1.75 Million - $2.17 Million	200,000 Added 8.62%	2,520,000 $27.3 Million
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $1.47 Million - $1.74 Million	153,276 Added 7.07%	2,320,000 $22.9 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $191,720 - $218,713	21,255 Added 0.99%	2,166,724 $21.6 Million
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $1.15 Million - $1.53 Million	125,000 Added 6.19%	2,145,469 $20.6 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $2.61 Million - $3.46 Million	299,216 Added 17.38%	2,020,469 $22.5 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $5.47 Million - $7.18 Million	644,980 Added 59.93%	1,721,253 $14.7 Million
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $1.01 Million - $1.24 Million	101,273 Added 10.39%	1,076,273 $11.3 Million
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $1.87 Million - $2.94 Million	190,657 Added 24.31%	975,000 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $657,006 - $797,755	54,343 Added 7.44%	784,343 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $570,889 - $651,891	43,086 Added 6.27%	730,000 $9.89 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $259,400 - $323,000	-20,000 Reduced 2.83%	686,914 $9.82 Million
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $2.15 Million - $2.93 Million	-158,086 Reduced 18.28%	706,914 $9.88 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $12.4 Million - $16.2 Million	865,000 New	865,000 $16.2 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callodine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Callodine Capital Management, LP with notifications on news.

Account

Callodine Capital Management, LP Viatris Inc Transaction History